期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

趋化因子CXCL10临床研究现状 被引量：6

Current Research of CXC Chemokine Ligand-10
下载PDF
导出
摘要 CXC趋化因子配体10(CXCL10)属于CXC趋化因子超家族的非ELR类,参与多种自身免疫性疾病。它不仅可以趋化白细胞向炎症部位聚集,而且可以减少肿瘤组织的血液供应,抑制肿瘤生长;同时CXCL10及其受体CXCR3在肝脏炎症、甲状腺滤泡上皮细胞及浸润的炎性细胞中表达均显著增高。现着重对趋化因子CXCL10及其受体的结构、生物学功能及与疾病的关系予以综述。 CXC chemokine ligand-10 belongs to the family of non-ELR-CXC chemokine,which participates in many autoimmune diseases.It can not only recruit specific subtypes of leukocytes to inflammation sites,but also reduce the blood supply to tumors and inhibit the growth of tumor.Meanwhile,CXCL10 and its receptor CXCR3 are significantly increased in liver inflammation,thyroid follicular epithelial cells and infiltration of inflammatory cells.This article reviewed the structure,biological function and the relationship of CXC chemokine ligand-10 and its receptor with multiple diseases.
作者 李守杰 高冠起
机构地区 泰山医学院研究生部 临沂市人民医院内分泌二科
出处 《医学综述》 2010年第12期1770-1772,共3页 Medical Recapitulate
关键词 CXC趋化因子配体10 疾病 免疫功能 CXC chemokine ligand-10 Disease Immune function
分类号 R392.11 [医药卫生—免疫学]
  • 相关文献

参考文献21

  • 1Strieter RM,Burdick MD,Mestas J,et al.Cancer CXC chemokine network and tumour angiogenesis[J].Eur J Cancer,2006,42(6):768-778.
  • 2Rctondi M,Chiovato L,Romagnani S,et al.Role of chemokines in endocrine autoimmune diseases[J].Endocr Rev,2007,28(5):492-520.
  • 3Antonelli A,Rotondi M,Fallahi P,et al.Iodine-131 given for thera-peutic purposes modulates differently interferon-γ-inducible α-che-mokine CXCL10 serum levels in patients with active Graves'dis-ease or toxic nodular goiter[J].J Clin Endocrinol Metab,2007,92(4):1485-1490.
  • 4Rotondi M,Falorni A,De Bellis A,et al.Elevated serum interferon-γ-inducible Chemokine-10/CXC chemokine ligand-10 in autoim-mune primary adrenal insufficiency and in vitro expression in hu-man adrenal cells primary cultures after stimulation with proinflam-matory cytokines[J].Clin Endocrinol Mctab,2005,90(23):2357-2363.
  • 5Lusmr AD,Unkeless JC,Ravetch IV.Gamma-interferon transerip-tionally regulates an early-response gene containing homology to platelet proteins[J].Nature,1985,315(6021):672-676.
  • 6Sato E,Fujimoto J,Toyoki H,et al.Expression of IP-10 related to angiogenesis in uterine cervical cancers[J].Br J Cancer,2007,96(11):1735-1739.
  • 7Charo IF,Ransohoff RM.The many roles of chemokines and che-mokine receptors in inflammation[J].N Engl J Med,2006,354(6):610-621.
  • 8周钢,谭锦泉,章晓联.趋化因子与移植免疫[J].国外医学（免疫学分册）,2004,27(4):185-189. 被引量：3
  • 9Persano L,Crescenzi M,Indraccolo S.Anti angiogenic gene therapy of cancer:current status and future prospects[J].Mol Aspects Med,2007,28(1):87-114.
  • 10Liu Y,Huang H,Saxena A,et al.Intratumoral coinjection of two adenoviral vectors expressing functional interleukin-18 and indue-ible protein-10,respectively,synergizes to facilitate regression of established tumors[J].Cancer Gene Ther,2002,9(6):533-542.

二级参考文献19

  • 1Morelli AE, Zahorchak AF, Larregina AT, et al.Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation [ J ].Blood, 2001, 98(5): 1512-1523.
  • 2Horiguchi K, Kitagawa-Sakakida S, Sawa Y, et al.Selective chemokine and reptor gene expressions in allografts that develop transplant vasculopathy[ J ].The Journal of heart and lung transplantation, 2002, 21(10): 1090-1100.
  • 3Wong BW, Wong D, McManus BM, et al.Characterization of fractalkine(CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease[J].Cardiovascular pathology, 2002, 11(6): 332-338.
  • 4Stojanovic T, Bedke J, Grone HJ, et al.Met-RANTES inhibition of mucosaI peffusion failure in acute intestinal transplant rejection-role of endothelial cell-leukocyte interaction[ J].J vascular research, 2002, 39(1 ):51-58.
  • 5Kikuchi T, Crystal RG.Antigen-pulsed dendritic cells expressing macrophage-derived chemokine elicit Th2 responses and promote specific humoral immunity[J].J Clin Invest, 2001, 108(6): 917-927.
  • 6Haskell CA, Ribeiro S, Horuk R.Chemokines in transplant rejection[J] .Current opinion in investigational drugs, 2002, 3(3): 399-405.
  • 7Akalin E, Neylan JF.The influence of Duffy blood group on renal allograft outcome in African Americans [ J ].Transplantation, 2003, 75(9): 1496-1500.
  • 8Iazzeri E, Lasagni L, Serio M, et al.Cytokines and chemokines in nephropathies and renaltransplant[J].G Ital Nefrol, 2002, 19(6): 641-649.
  • 9Segerer S, Hughes E, Hudkins KL, et al.Expression of the fractalkine receptor (CX3CR1) in human kidney diseases[ J].Kidney international, 2002, 62(2): 488-495.
  • 10Bedard EL, Kim P, Jiang J, et al.Chemokine-binding viral protein MT7 prevents chronic rejection in rat renal allografts[J].Transplantation,2003, 76(1 ): 249-252.

共引文献2

同被引文献115

引证文献6

二级引证文献47

医学综述
2010年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部